CCR5 and leukemia: This includes the two well-documented cases of the “Berlin Patient” and “London Patient” who received allogeneic hemopoietic stem cell transplants with CCR5 Δ32 mutations during their treatment for leukemia or Hodgkin lymphoma, respectively (118–120).